ViralClear adds St. David's HealthCare in Austin, Texas, to its Planned Phase II trial for its Broad-Spectrum Oral Anti-Viral Candidate for COVID-19

Stock Information for BioSig Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.